SALT LAKE CITY, Nov. 29, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes, today ...
The new product, known as Protandim® NAD Synergizer™, is the company’s first such addition to the flagship line since the launch of Protandim® Nrf1 Synergizer™ in 2016.* “Our Protandim® line of ...
In non-small-cell lung cancer (NSCLC) and various other cancers, mutations in nuclear factor erythroid 2-related factor 2 (NRF2) cause aberrant activation of NRF2 transcriptional activity, resulting ...
Alpha-fetoprotein up-regulated the expression of c-Src in hepatoma cells is PTEN/AKT signaling pathway dependent or independent. Background: We previously demonstrated that transcription factor Nrf2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results